http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3663761-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dee4d0256899079a7834618d7051211
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-0092
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54393
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54313
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-531
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531
filingDate 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d83dca59d6f0adf93ae9a50a1afbe9e8
publicationDate 2020-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3663761-A1
titleOfInvention Degradation preventing means for immunoassay reagent containing insoluble carrier particles
abstract An object of the present invention is to find a component which can prevent non-specific flocculation of sensitized or unsensitized insoluble carrier particles contained in an immunoassay reagent when the reagent is frozen, to thereby provide means for preventing degradation of the immunoassay reagent. The component which can prevent non-specific flocculation of insoluble carrier particles is the following ω-aminocarboxylic acid (1) [wherein n is an integer of 2 to 6]. The invention provides an immunoassay reagent containing insoluble carrier particles and ω-aminocarboxylic acid (1), and a method for preventing degradation of an immunoassay reagent by using ω-aminocarboxylic acid (1).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11597787-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021122863-A1
priorityDate 2017-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235324151
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8P2T7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226528179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413496829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6992101
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ53957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448545747
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DF96
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7427
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DF97
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0I3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID239
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54114
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID181978
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5XE40
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88544956
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540167

Total number of triples: 48.